Health Catalyst, Inc. (HCAT) Return on equity 2019–2025
Health Catalyst, Inc. (HCAT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-72.4%FY2025 · since FY2019: -30.0% → -72.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -72.4% | -53.4 pp |
| FY2024 | -19.0% | +13.2 pp |
| FY2023 | -32.2% | +0.1 pp |
| FY2022 | -32.3% | -3.0 pp |
| FY2021 | -29.3% | +12.3 pp |
| FY2020 | -41.7% | -11.7 pp |
| FY2019 | -30.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice